MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
137.79
+1.92
+1.41%
After Hours: 137.35 -0.44 -0.32% 19:28 03/27 EDT
OPEN
136.56
PREV CLOSE
135.87
HIGH
137.81
LOW
135.83
VOLUME
1.27M
TURNOVER
0
52 WEEK HIGH
141.16
52 WEEK LOW
111.62
TOTAL ASSET
7.66B
YTD YIELD
9.65%
1D
5D
1M
3M
1Y
5Y
Health Care Sector Update for 03/27/2024: NVCR, MRK, MRNA, XLV, IBB
NASDAQ · 1d ago
IBB: Let It Rest
IShares Biotechnology ETF (IBB) has underperformed the broader market and remains in the range set last year. It has been a lagging sector over the last five years and is likely to consolidate for a long period. The top 10 stocks in IBB's portfolio have flat revenues and are no longer growth stocks. IBB is a Fund to avoid for now and a long sideways consolidation could develop.
Seeking Alpha · 2d ago
Health Care Sector Update for 03/25/2024: MASI, ESPR, OCGN, XLV, IBB
NASDAQ · 3d ago
Weekly Report: what happened at IBB last week (0318-0322)?
Weekly Report · 3d ago
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
NASDAQ · 3d ago
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 5d ago
Health Care Sector Update for 03/22/2024: ETON, OTLK, STVN, XLV, IBB
NASDAQ · 6d ago
Health Care Sector Update for 03/20/2024: BNTX, AQST, VERA, XLV, IBB
NASDAQ · 03/20 13:08
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank NA
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead